Five Prime Therapeutics was a biotechnology company acquired by Amgen in April 2021.
Facts compiled by Executive Moves from publicly available news and press releases on 9 September 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Light company · auto-generated
Are you on the Five Prime Therapeutics team?
This is a Light company page, auto-generated from public news coverage. Claim it to verify the company description, add logo and links, and control how your organisation is represented on Executive Moves.
Claim this company →
